Great News: Blood Test For Cancer
From Science Daily, a blood test developed by Kansas State University researchers accurately detects early stages of breast and lung cancer in humans:
In less than an hour, the test can detect breast cancer and non-small lung cancer -- the most common type of lung cancer -- before symptoms like coughing and weight loss start. The researchers anticipate testing for the early stages of pancreatic cancer shortly.The test was developed by Stefan Bossmann, professor of chemistry, and Deryl Troyer, professor of anatomy and physiology. Both are also researchers affiliated with Kansas State University's Johnson Cancer Research Center and the University of Kansas Cancer Center. Gary Gadbury, professor of statistics at Kansas State University, helped analyze the data from tests with lung and breast cancer patients.
..."The problem, though, is that nobody knows they're in stage 1," Bossmann said. "There is often not a red flag to warn that something is wrong. Meanwhile, the person is losing critical time."
The test developed by Kansas State University's Bossmann and Troyer works by detecting increased enzyme activity in the body. Iron nanoparticles coated with amino acids and a dye are introduced to small amounts of blood or urine from a patient. The amino acids and dye interact with enzymes in the patient's urine or blood sample. Each type of cancer produces a specific enzyme pattern, or signature, that can be identified by doctors.







PETA springs into action looking for harmed animals.
God, I love the people that do this research. Auto mechanics too.
Dave B at September 27, 2012 5:51 PM
Offtopic: Yeah Baby, Yeah!
Crid [CridComment at gmail] at September 27, 2012 8:00 PM
Yes, but will the test(s) be paid for under ObamaTax or will the death panel declare it too expensive?
WE need death panels:
Note that Steven Rattner, who wrote the op-ed, was the former "Car Czar" and had various other positions -- he's an economist not a part of the medical field.
This is what you are getting under ObamaTax. The invisible hand of the market currently (used to) drive the research; and the rise and fall of drugs. Anyone remember Laetrile? How about Aricept® -- depending on dosage it makes only about 3-6 months difference on the way to dementia. But the study of a large number of people and commercial use brings down cost and shows whether it works.
But a panel of fifteen people, not necessarily doctors and medical research scientists, would be the final arbiter of what drugs are approved for payment.
Think about it.
Jim P. at September 27, 2012 8:33 PM
Didnt I hear about this last year? When a middle school or high school student did it?
lujlp at September 28, 2012 12:07 PM
Leave a comment